Susan E Bates, MD
Columbia University · National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Susan E Bates, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05241249 · Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic AdenocarcinomaSusan E. Bates · recruiting · Pancreas Cancer · principal investigator
- Early Ph1NCT03572283 · Bethanechol Prior to Pancreatic SurgeryColumbia University · completed · Pancreas Cancer · principal investigator
- Ph2NCT03264404 · Azacitidine and Pembrolizumab in Pancreatic CancerSusan E. Bates · completed · Pancreas Cancer · principal investigator
- Ph1NCT00019318 · Depsipeptide in Treating Patients With Solid TumorsNational Cancer Institute (NCI) · completed · Lymphoma · study chair
- Ph2NCT00019812 · Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2National Institutes of Health Clinical Center (CC) · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.